Medulloblastoma cell invasion is inhibited by green tea (−)epigallocatechin-3-gallate
✍ Scribed by Anthony Pilorget; Virginie Berthet; José Luis; Albert Moghrabi; Borhane Annabi; Richard Béliveau
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 193 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Epigallocatechin‐3‐gallate (EGCG), the major green tea polyphenol, can reach the brain following oral intake and could thus act as an anti‐tumoral agent targeting several key steps of brain cancer cells invasive activity. Because integrin‐mediated extracellular matrix recognition is crucial during the cell adhesion processes involved in carcinogenesis, we have investigated the effects of EGCG on different cellular integrins of the pediatric brain tumor‐derived medulloblastoma cell line DAOY. Using flow cytometry, we report the levels of expression of several cell surface integrins in DAOY. These include high expression of α2, α3, and β1 integrins, as well as αv and β3 integrins. Moreover, we provide evidence that EGCG can antagonize DAOY cell migration specifically on collagen by increasing cell adhesive ability through specific gene and protein upregulation of the β1 integrin subunit. Our results suggest that this naturally occurring green tea polyphenol may thus be used as a nutraceutical therapeutic agent in targeting the invasive character of medulloblastomas. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Tea, one of the most widely consumed beverages worldwide, has been shown to have anti‐cancer activity in various cancers including colon cancer. It has been demonstrated that overexpression of the inducible isoform of cyclooxygenase (COX‐2) occurs during colon tumorigenesis and inhibiti
## Abstract Green tea infusion has been shown to inhibit metastatic spreading of the transgenic adenocarcinoma of mouse prostate (TRAMP). Investigation on the molecular mechanisms triggered by the main green tea flavonoid, (−)epigallocatechin‐3‐gallate (EGCG), shows that EGCG restrains TRAMP‐C1 cel